The announcement of a long-term exclusive supply agreement is typically viewed positively by the market, as it secures a steady revenue stream and potentially enhances the company's market position. This deal with Cartessa Aesthetics is likely to be seen as a strong vote of confidence in BioRestorative Therapies' offerings and could lead to increased investor interest and a higher stock price in the short term.